ALECTOR INC. - COMMON STOCK

Alector to Participate in Upcoming Healthcare Conferences

28 أغسطس 2025 05:00:00 بحسب Nasdaq GlobeNewswire

Alector Reports Second Quarter 2025 Financial Results and Provides Business Update

07 أغسطس 2025 13:05:02 بحسب Nasdaq GlobeNewswire

Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call

31 يوليو 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Alector Provides Executive Leadership Update

13 يونيو 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

03 يونيو 2025 05:00:00 بحسب Nasdaq GlobeNewswire

Alector Reports First Quarter 2025 Financial Results and Provides Business Update

08 مايو 2025 13:05:03 بحسب Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

06 مايو 2025 05:00:02 بحسب Nasdaq GlobeNewswire

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease

17 أبريل 2025 05:00:00 بحسب Nasdaq GlobeNewswire

Alector Provides Executive Leadership Update

28 مارس 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

26 فبراير 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

25 فبراير 2025 05:00:00 بحسب Nasdaq GlobeNewswire

Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call

19 فبراير 2025 13:05:00 بحسب Nasdaq GlobeNewswire

Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025

13 يناير 2025 05:00:00 بحسب Nasdaq GlobeNewswire

Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update

25 نوفمبر 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital

14 نوفمبر 2024 13:05:46 بحسب Nasdaq GlobeNewswire

Alector Reports Third Quarter 2024 Financial Results and Provides Business Update

06 نوفمبر 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)

19 سبتمبر 2024 05:00:00 بحسب Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

29 أغسطس 2024 04:00:00 بحسب Nasdaq GlobeNewswire

Alector Reports Second Quarter 2024 Financial Results and Provides Business Update

07 أغسطس 2024 13:05:00 بحسب Nasdaq GlobeNewswire

Alector to Host Mid-Year Earnings Conference Call

31 يوليو 2024 13:05:00 بحسب Nasdaq GlobeNewswire